Asthma exacerbations during long term (cid:226) agonist use: influence of (cid:226) 2 adrenoceptor polymorphism

Background —Polymorphisms of the

[1]  E. Silverman,et al.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. , 2000, American journal of respiratory and critical care medicine.

[2]  D. Thomason,et al.  Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics , 1999, Clinical pharmacology and therapeutics.

[3]  S. Liggett,et al.  Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. , 1998, The Journal of clinical investigation.

[4]  G. Town,et al.  Asthma control during long term treatment with regular inhaled salbutamol and salmeterol , 1998, Thorax.

[5]  T D Weir,et al.  beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. , 1998, American journal of respiratory and critical care medicine.

[6]  Britton,et al.  β2‐adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  R. Erickson,et al.  Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. , 1997, The Journal of clinical investigation.

[8]  Brian Lipworth,et al.  Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics , 1997, The Lancet.

[9]  S. Liggett.  Polymorphisms of the β2-Adrenergic Receptor and Asthma , 1997 .

[10]  The British Guidelines on Asthma Management1995 Review and Position Statement , 1997 .

[11]  I. Hall.  Beta 2 adrenoceptor polymorphisms: are they clinically important? , 1996, Thorax.

[12]  M. Cowles,et al.  Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. , 1995, American journal of respiratory and critical care medicine.

[13]  I. Hall,et al.  Association of Glu 27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects , 1995, The Lancet.

[14]  S. Green,et al.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.

[15]  R. Reisman,et al.  Asthma induced by adrenergic aerosols. , 1970, Chest.

[16]  R. Hancox,et al.  Polymorphism of the β2-adrenoceptor and the response to long-term β2-agonist therapy in asthma , 2002 .

[17]  J. FitzGerald,et al.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. , 1998, The New England journal of medicine.

[18]  B. Korf,et al.  ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency , 1996, Journal of clinical laboratory analysis.

[19]  M. Lara,et al.  Guidelines For The Diagnosis And Management Of Asthma , 1992, The Journal of the American Board of Family Medicine.

[20]  W. Eisenstadt,et al.  The adverse effect of adrenergic aerosols in bronchial asthma. , 1969, Annals of allergy.

[21]  D. Cockcroft,et al.  Functional antagonism : tolerance produced by inhaled 32 agonists , 2022 .

[22]  adrenoceptor polymorphisms : are they clinically important ? , 2022 .